HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Virtual tissue microarrays: a novel and viable approach to optimizing tissue microarrays for biomarker research applied to ductal carcinoma in situ.

AbstractAIMS:
Tissue microarrays (TMAs) are effective tools for performing high-throughput standardization analyses of biomarkers, but evidence indicating the core number required to be representative of the whole tumour is lacking. Ductal carcinoma in situ (DCIS) is a non-obligate precursor of invasive breast cancer. The number and size of cores that can best represent a DCIS lesion are unknown. Rather than performing extensive experiments using several variants of physical TMAs, the aim of this study was to develop a 'virtual TMA' approach that is effective at optimizing biomarker discovery and validation.
METHODS AND RESULTS:
Whole DCIS sections from 95 patients were evaluated by immunohistochemistry for oestrogen receptor (ER), progesterone receptor (PgR), HER2, and Ki67. Histoscores were generated manually for ER, PgR, and HER2, as well as percentage positivity for Ki67. Slides were scanned using the FDA-approved Ariol SL50 Image Analysis system, and the virtual array (V-Array) module was used. Virtual cores created virtual TMAs, and our validated scoring classifiers were applied. Automated histoscores and percentage positivity were determined, and compared against increasing numbers of cores. The optimal number of cores was based on concordant results between virtual TMAs and corresponding whole sections.
CONCLUSIONS:
We have shown that virtual arrays constitute an important tool in digital pathology in both research and clinical settings.
AuthorsMary Anne Quintayo, Jane Starczynski, Fu Jian Yan, Hanna Wedad, Sharon Nofech-Mozes, Eileen Rakovitch, John M S Bartlett
JournalHistopathology (Histopathology) Vol. 65 Issue 1 Pg. 2-8 (Jul 2014) ISSN: 1365-2559 [Electronic] England
PMID24267587 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Copyright© 2013 John Wiley & Sons Ltd.
Chemical References
  • Biomarkers, Tumor
  • Receptors, Estrogen
  • Receptors, Progesterone
  • Receptor, ErbB-2
Topics
  • Biomarkers, Tumor (analysis)
  • Breast Neoplasms
  • Carcinoma in Situ
  • Carcinoma, Ductal, Breast
  • Female
  • Humans
  • Image Processing, Computer-Assisted (methods)
  • Immunohistochemistry
  • Receptor, ErbB-2 (analysis)
  • Receptors, Estrogen (analysis)
  • Receptors, Progesterone (analysis)
  • Tissue Array Analysis (methods)
  • User-Computer Interface

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: